Rockefeller University – Developmental Therapeutics Review – Q4 2010

Date: November 1, 2010
Pages: 50
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: R013AFF2843EN
Leaflet:

Download PDF Leaflet

Rockefeller University – Developmental Therapeutics Review – Q4 2010
Rockefeller University – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Rockefeller University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope
  • Review of therapeutics under development by Rockefeller University.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Rockefeller University with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of Rockefeller University’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.

Reasons to buy
  • Identify new drug targets and therapeutic classes in Rockefeller University’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
  • Evaluate Rockefeller University’s position with total access to a detailed information on its therapeutic products development.
  • Assess the growth potential of Rockefeller University in its therapy areas of focus.
  • Exploit collaboration and partnership opportunities with Rockefeller University.
  • Avoid Intellectual Property Rights related issues.
Rockefeller University Snapshot
Rockefeller University Overview
Key Information
Key Facts
Rockefeller University – Research and Development Overview
Key Therapeutic Areas
Rockefeller University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Rockefeller University – Pipeline Products Glance
Rockefeller University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Rockefeller University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Rockefeller University – Drug Profiles
Etanercept
  Product Description
  Mechanism of Action
  R&D Progress
A-100
  Product Description
  Mechanism of Action
  R&D Progress
Anti-TAC + Cyclosporine
  Product Description
  Mechanism of Action
  R&D Progress
Autologous Dendritic Cell Vaccine
  Product Description
  Mechanism of Action
  R&D Progress
DC/LNCaP
  Product Description
  Mechanism of Action
  R&D Progress
Maraviroc for Antiviral and Immunological Effects
  Product Description
  Mechanism of Action
  R&D Progress
Truvada + Darunavir + Ritonavir
  Product Description
  Mechanism of Action
  R&D Progress
Truvada + Darunavir + Ritonavir + Maraviroc + Raltegravir
  Product Description
  Mechanism of Action
  R&D Progress
DC/AAT + DC/AAT-Flu + DC/KLH
  Product Description
  Mechanism of Action
  R&D Progress
DCVax-001 + Poly-ICLC
  Product Description
  Mechanism of Action
  R&D Progress
Poly-ICLC
  Product Description
  Mechanism of Action
  R&D Progress
Vitamin D + Calcium
  Product Description
  Mechanism of Action
  R&D Progress
Rockefeller University – Pipeline Analysis
Rockefeller University – Pipeline Products by Therapeutic Class
Rockefeller University Pipeline Products By Target
Rockefeller University – Pipeline Products by Route of Administration
Rockefeller University – Pipeline Products by Molecule Type
Rockefeller University - Dormant Projects
Rockefeller University – Locations And Subsidiaries
Head Office
Recent Developments
May 08, 2001: Rockefeller University Begins Leptin Replacement Therapy Study In Obese Women
Aug 04, 1997: Resistance To Leptin Contributes To Obesity In A Study Conducted By Rockefeller University
Financial Deals Landscape
Rockefeller University, Deals Volume Summary, 2004 to YTD 2010
Rockefeller University, Deals Summary By Region, 2004 to YTD 2010
Rockefeller University, Deals Summary, 2004 to YTD 2010
Rockefeller University Detailed Deal Summary
Asuragen Partners With The Rockefeller University
Asset Finance
GHECO-One Completes Project Financing Of $800 Million For Coal-Fired IPP Power Plant Project
Licensing Agreements
Sanofi-aventis Enters Into A Licensing Agreement With Rockefeller University
Celldex Therapeutics Enters Into Licensing Agreement With The Rockefeller University
BioVeris Enters Into Licensing Agreement With Rockefeller University
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Rockefeller University – Pipeline by Therapy Area and Indication, 2010
Rockefeller University – Pipeline by Stage of Development, 2010
Rockefeller University – Monotherapy Products in Pipeline, 2010
Rockefeller University – Combination Treatment Modalities in Pipeline, 2010
Rockefeller University – Phase III, 2010
Rockefeller University - Phase II, 2010
Rockefeller University - Phase I, 2010
Rockefeller University - Pipeline By Therapeutic Class, 2010
Rockefeller University - Pipeline By Target, 2010
Rockefeller University – Pipeline By Route of Administration, 2010
Rockefeller University – Pipeline By Molecule Type, 2010
Rockefeller University - Dormant Developmental Projects, 2010
Rockefeller University, Deals Summary, 2004 to YTD 2010
Rockefeller University, Deals Summary by Region, 2004 to YTD 2010
Rockefeller University, Deals Summary, 2004 to YTD 2010 41

LIST OF FIGURES

Rockefeller University – Pipeline by Therapy Area and Indication, 2010
Rockefeller University – Pipeline by Stage of Development, 2010
Rockefeller University – Monotherapy Products in Pipeline, 2010
Rockefeller University – Combination Treatment Modalities in Pipeline, 2010
Rockefeller University – Pipeline By Therapeutic Class, 2010
Rockefeller University - Pipeline By Target, 2010
Rockefeller University – Pipeline By Route of Administration, 2010
Rockefeller University – Pipeline By Molecule Type, 2010 35

Ask Your Question

Rockefeller University – Developmental Therapeutics Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: